Opinion|Videos|October 11, 2024
Older Adults, High-Risk Populations, and Severe Illness
Author(s)Carrie Koenigsfeld, PharmD, FAPhA
Key Takeaways
- Older adults, especially those with chronic heart or lung diseases, are at high risk for severe RSV illness.
- Severe RSV can result in hospitalization, long-term respiratory complications, and increased mortality in older adults.
Carrie Koenigsfeld, PharmD, FAPhA, discusses the CDC’s recommendation for an RSV vaccine for all adults aged 75 years and older, as well as those aged 60 to 74 years at increased risk, and outlines the conditions that elevate the risk for severe illness, including the implications of severe illness, such as hospitalization, long-term effects, complications, comorbidities, and mortality, while also comparing how RSV infection affects older vs younger adults.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- The CDC recommends an RSV vaccine for all adults aged 75 years and older and for adults aged 60 to 74 years who are at increased risk for severe RSV. What conditions put an individual at high risk for developing severe illness?
- Describe the implications of severe illness (ie, hospitalization, long-term effects, complications, comorbidities, mortality).
- How does RSV infection affect older vs younger adults?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Federal Health Officials Scale Back Number of Recommended Vaccines for Children
2
GoodRx Expands Access to Oral GLP-1 Therapy With Semaglutide Pill Cash Pricing
3
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
4
Former FDA Chief Scientist Jesse Goodman Breaks Down the Implications of Pediatric Vaccine Guideline Changes
5